Occupe actuellement des postes chez Aimmune Therapeutics Inc and Cerus Corp
Position | Company | Period |
---|---|---|
Chief Financial Officer | Aimmune Therapeutics Inc | 1 décembre 2019 - |
Independent Director | Cerus Corp | 9 octobre 2018 - |
Chief Financial Officer | Aimmune Therapeutics Inc | 13 avril 2017 - 1 décembre 2019 |
Independent Director | Corium International Inc | 1 avril 2015 - 26 novembre 2018 |
Chief Financial Officer, Executive Vice President - Corporate Development and Finance, Corporate Secretary | Sunesis Pharmaceuticals Inc | 1 janvier 2016 - 7 avril 2017 |
Independent Director | Microbot Medical Inc | 1 mars 2004 - 28 novembre 2016 |
Chief Financial Officer, Executive Vice President - Corporate Development and Finance | Sunesis Pharmaceuticals Inc | 2 février 2012 - 1 janvier 2016 |
Chief Financial Officer, Senior Vice President - Corporate Development and Finance | Sunesis Pharmaceuticals Inc | 1 février 2007 - 2 février 2012 |
Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur totale | Détails | |
---|---|---|---|---|---|---|---|---|
2024-03-27 | 2024-03-27 |
Mirum Pharmaceuticals Inc
(MIRM)
|
A Achat |
2 000
+16.7%
24,8049 600 USD |
2 000 +16.7% | 24,80 | 49 600 USD | |
2024-03-18 | 2024-03-18 |
Mirum Pharmaceuticals Inc
(MIRM)
|
A Achat |
2 000
+20.0%
25,8051 600 USD |
2 000 +20.0% | 25,80 | 51 600 USD | |
2023-12-13 | 2023-12-13 |
Cerus Corp
(CERS)
|
A Achat |
10 000
+7.6%
1,6216 200 USD |
10 000 +7.6% | 1,62 | 16 200 USD | |
2023-09-12 | 2023-09-11 |
Mirum Pharmaceuticals Inc
(MIRM)
|
A Achat |
10 000
+inf%
29,65296 492 USD |
10 000 +inf% | 29,65 | 296 492 USD | |
2023-08-23 | 2023-08-21 |
Cerus Corp
(CERS)
|
A Achat |
10 000
+8.2%
1,7217 151 USD |
10 000 +8.2% | 1,72 | 17 151 USD | |
2023-05-24 | 2023-05-23 |
Graybug Vision Inc
(GRAY)
|
A Achat |
500
+17.1%
3,271 634 USD |
500 +17.1% | 3,27 | 1 634 USD | |
2023-05-23 | 2023-05-23 |
Cerus Corp
(CERS)
|
A Achat |
5 000
+6.5%
2,0010 000 USD |
5 000 +6.5% | 2,00 | 10 000 USD | |
2023-05-22 | 2023-05-19 |
Graybug Vision Inc
(GRAY)
|
A Achat |
199
+7.3%
2,65527 USD |
199 +7.3% | 2,65 | 527 USD | |
2023-05-22 | 2023-05-18 |
Graybug Vision Inc
(GRAY)
|
A Achat |
1
+0.0%
2,653 USD |
1 +0.0% | 2,65 | 3 USD | |
2023-05-18 | 2023-05-18 |
Graybug Vision Inc
(GRAY)
|
A Achat |
300
+12.4%
2,70810 USD |
300 +12.4% | 2,70 | 810 USD | |
2023-05-18 | 2023-05-17 |
Graybug Vision Inc
(GRAY)
|
A Achat |
200
+9.0%
2,67534 USD |
200 +9.0% | 2,67 | 534 USD | |
2023-05-18 | 2023-05-16 |
Graybug Vision Inc
(GRAY)
|
A Achat |
800
+56.0%
2,702 160 USD |
800 +56.0% | 2,70 | 2 160 USD | |
2023-02-15 | 2023-02-10 |
Aduro Biotech Inc
(ADRO)
|
V Vente |
857
-2.2%
23,7520 352 USD |
857 -2.2% | 23,75 | 20 352 USD | |
2023-02-02 | 2023-01-31 |
Aduro Biotech Inc
(ADRO)
|
V Vente |
2 891
-7.2%
24,6871 357 USD |
2 891 -7.2% | 24,68 | 71 357 USD | |
2022-12-02 | 2022-12-01 |
Aduro Biotech Inc
(ADRO)
|
V Vente |
5 770
-14.9%
22,29128 602 USD |
5 770 -14.9% | 22,29 | 128 602 USD | |
2022-02-14 | 2022-02-11 |
Aduro Biotech Inc
(ADRO)
|
V Vente |
895
-3.9%
12,7411 403 USD |
895 -3.9% | 12,74 | 11 403 USD | |
2020-03-12 | 2020-03-12 |
Aimmune Therapeutics Inc
(AIMT)
|
A Achat |
1 000
+2.4%
15,1015 100 USD |
1 000 +2.4% | 15,10 | 15 100 USD | |
2020-03-10 | 2020-03-09 |
Aimmune Therapeutics Inc
(AIMT)
|
A Achat |
1 000
+2.4%
18,9718 970 USD |
1 000 +2.4% | 18,97 | 18 970 USD | |
2020-02-03 | 2020-01-29 |
Cerus Corp
(CERS)
|
A Achat |
20 000
+467.1%
4,1583 000 USD |
20 000 +467.1% | 4,15 | 83 000 USD | |
2019-09-20 | 2019-09-18 |
Aimmune Therapeutics Inc
(AIMT)
|
A Achat |
1 550
+4.8%
22,5734 977 USD |
1 550 +4.8% | 22,57 | 34 977 USD | |
2018-06-14 | 2018-06-13 |
Aimmune Therapeutics Inc
(AIMT)
|
AP Achat planifié |
1 600
+8.9%
30,4148 663 USD |
1 600 +8.9% | 30,41 | 48 663 USD |